A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age

  • Habibul Ahsan
  • Jerry Halpern
  • Muhammad G Kibriya
  • Brandon L Pierce
  • Lin Tong
  • Eric Gamazon
  • Valerie McGuire
  • Anna Felberg
  • Jianxin Shi
  • Farzana Jasmine
  • Shantanu Roy
  • Rachelle Brutus
  • Maria Argos
  • Stephanie Melkonian
  • Jenny Chang-Claude
  • Irene Andrulis
  • John L Hopper
  • Esther M John
  • Kathi Malone
  • Giske Ursin
  • Marilie D Gammon
  • Duncan C Thomas
  • Daniela Seminara
  • Graham Casey
  • Julia A Knight
  • Melissa C Southey
  • Graham G Giles
  • Regina M Santella
  • Eunjung Lee
  • David Conti
  • David Duggan
  • Steve Gallinger
  • Robert Haile
  • Mark Jenkins
  • Noralane M Lindor
  • Polly Newcomb
  • Kyriaki Michailidou
  • Carmel Apicella
  • Daniel J Park
  • Julian Peto
  • Olivia Fletcher
  • Isabel dos Santos Silva
  • Mark Lathrop
  • David J Hunter
  • Stephen J Chanock
  • Alfons Meindl
  • Rita K Schmutzler
  • Bertram Müller-Myhsok
  • Magdalena Lochmann
  • Lars Beckmann
  • Rebecca Hein
  • Enes Makalic
  • Daniel F Schmidt
  • Quang Minh Bui
  • Jennifer Stone
  • Dieter Flesch-Janys
  • Norbert Dahmen
  • Heli Nevanlinna
  • Kristiina Aittomäki
  • Carl Blomqvist
  • Per Hall
  • Kamila Czene
  • Astrid Irwanto
  • Jianjun Liu
  • Nazneen Rahman
  • Clare Turnbull
  • Alison M Dunning
  • Paul Pharoah
  • Quinten Waisfisz
  • Hanne Meijers-Heijboer
  • Andre G Uitterlinden
  • Fernando Rivadeneira
  • Dan Nicolae
  • Douglas F Easton
  • Nancy J Cox
  • Alice S Whittemore
  • Familial Breast Cancer Study

Abstract

Early-onset breast cancer (EOBC) causes substantial loss of life and productivity, creating a major burden among women worldwide. We analyzed 1,265,548 Hapmap3 single-nucleotide polymorphisms (SNP) among a discovery set of 3,523 EOBC incident cases and 2,702 population control women ages ≤ 51 years. The SNPs with smallest P values were examined in a replication set of 3,470 EOBC cases and 5,475 control women. We also tested EOBC association with 19,684 genes by annotating each gene with putative functional SNPs, and then combining their P values to obtain a gene-based P value. We examined the gene with smallest P value for replication in 1,145 breast cancer cases and 1,142 control women. The combined discovery and replication sets identified 72 new SNPs associated with EOBC (P < 4 × 10(-8)) located in six genomic regions previously reported to contain SNPs associated largely with later-onset breast cancer (LOBC). SNP rs2229882 and 10 other SNPs on chromosome 5q11.2 remained associated (P < 6 × 10(-4)) after adjustment for the strongest published SNPs in the region. Thirty-two of the 82 currently known LOBC SNPs were associated with EOBC (P < 0.05). Low power is likely responsible for the remaining 50 unassociated known LOBC SNPs. The gene-based analysis identified an association between breast cancer and the phosphofructokinase-muscle (PFKM) gene on chromosome 12q13.11 that met the genome-wide gene-based threshold of 2.5 × 10(-6). In conclusion, EOBC and LOBC seem to have similar genetic etiologies; the 5q11.2 region may contain multiple distinct breast cancer loci; and the PFKM gene region is worthy of further investigation. These findings should enhance our understanding of the etiology of breast cancer.

Bibliographical data

Original languageEnglish
ISSN1055-9965
DOIs
Publication statusPublished - 01.04.2014
PubMed 24493630